Nilofer S Azad

14PUBLICATIONS
110CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 16, 2026
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts.

|Jun 26, 2026
Peripheral Th17 immune signature associates with excellent response to anti-PD1/anti-PD-L1 therapy across solid tumors.

|Apr 21, 2026
Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinoma.

|Sep 15, 2025
Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy.

Howard L Li, Soren Charmsaz, Mari Nakazawa

|Mar 27, 2025
Anti-CTLA4 Therapy Leads to Early Expansion of a Peripheral Th17 Population and Induction of Th1 Cytokines.

Mari Nakazawa, Soren Charmsaz, Elsa Hallab

|Feb 19, 2025
Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging.

Marina Baretti, Soumya Shekhar, Vaibhav Sahai

Pageof 3

Frequent Collaborators

10 joint publications

Mark Yarchoan

7 joint publications

Won Jin Ho

5 joint publications

Elizabeth M Jaffee

5 joint publications

Christopher Thoburn